Stocks and Investing
Stocks and Investing
Fri, December 17, 2021
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
[ Fri, Dec 17th 2021
] - WOPRAI
Thu, December 16, 2021
[ Thu, Dec 16th 2021
] - WOPRAI
[ Thu, Dec 16th 2021
] - WOPRAI
[ Thu, Dec 16th 2021
] - WOPRAI
[ Thu, Dec 16th 2021
] - WOPRAI
Andrew Fein Initiated (TCRX) at Strong Buy and Held Target at $21 on, Dec 16th, 2021
Andrew Fein of HC Wainwright & Co., Initiated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $21 on, Dec 16th, 2021.
Andrew, nor any peers, have made any analyst calls on TCRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources